AR049096A1 - Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistas - Google Patents
Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistasInfo
- Publication number
- AR049096A1 AR049096A1 ARP050101959A ARP050101959A AR049096A1 AR 049096 A1 AR049096 A1 AR 049096A1 AR P050101959 A ARP050101959 A AR P050101959A AR P050101959 A ARP050101959 A AR P050101959A AR 049096 A1 AR049096 A1 AR 049096A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- halogen
- hydrogen
- enantiomers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Reivindicacion 1: Formulacion medicamentosa que contiene como unico principio activo uno o varios compuestos de la formula general (1), en la que significan: R1 es hidrogeno, alquilo C1-4, alcoxi C1-4 o halogeno; R2 es hidrogeno, alquilo C1-4, alcoxi C1-4 o halogeno; R3 es hidrogeno, alquilo C1-4, alcoxi C1-4 o halogeno, OH, -O-alquilenC1-4-COOH u -O-alquilen-C1-4-COO-alquiloC1-4; X- anion de carga negativa simple, con preferencia un anion de carga negativa simple seleccionado del grupo compuesto por cloruro, bromuro, yoduro, sulfato, fosfato, metansulfonato, nitrato, maleato, acetato, benzoato, citrato, salicilato, trifluoroacetato, fumarato, tartrato, oxalato, succinato, benzoato y ptoluensulfonato; eventualmente en forma de sus tautomeros, enantiomeros, mezclas de enantiomeros, racematos o solvatos, al menos un ácido farmacologicamente tolerable, eventualmente otros coadyuvantes y/o formadores de complejos farmacologicamente tolerables, y como disolvente agua, etanol o una mezcla de agua y etanol.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004024452A DE102004024452A1 (de) | 2004-05-14 | 2004-05-14 | Aerosolformulierung für die Inhalation von Betaagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049096A1 true AR049096A1 (es) | 2006-06-28 |
Family
ID=34979667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050101959A AR049096A1 (es) | 2004-05-14 | 2005-05-13 | Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistas |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1809293B1 (es) |
| JP (1) | JP4620730B2 (es) |
| KR (1) | KR101288791B1 (es) |
| CN (1) | CN101056640A (es) |
| AR (1) | AR049096A1 (es) |
| AU (1) | AU2005244414B2 (es) |
| BR (1) | BRPI0511135B8 (es) |
| CA (1) | CA2564379C (es) |
| DE (1) | DE102004024452A1 (es) |
| DK (1) | DK1809293T3 (es) |
| EA (1) | EA012583B1 (es) |
| EC (1) | ECSP067004A (es) |
| ES (1) | ES2575925T3 (es) |
| HU (1) | HUE027780T2 (es) |
| IL (1) | IL179218A (es) |
| MX (1) | MXPA06013216A (es) |
| MY (1) | MY148403A (es) |
| NO (1) | NO20065030L (es) |
| PE (1) | PE20060311A1 (es) |
| PL (1) | PL1809293T3 (es) |
| SG (1) | SG152265A1 (es) |
| TW (1) | TWI356703B (es) |
| UA (1) | UA87312C2 (es) |
| UY (1) | UY28891A1 (es) |
| WO (1) | WO2005110421A2 (es) |
| ZA (1) | ZA200607462B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| ES2530991T3 (es) | 2005-08-15 | 2015-03-09 | Boehringer Ingelheim Int | Procedimiento para la obtención de betamiméticos |
| AU2006311060A1 (en) * | 2005-11-09 | 2007-05-18 | Boehringer Ingelheim International Gmbh | Aerosolformulation for inhalation |
| UY30543A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
| CA2738616A1 (en) * | 2008-11-21 | 2010-05-27 | Boehringer Ingelheim International Gmbh | Aerosol formulation for the inhalation of beta agonists |
| JP2012509299A (ja) * | 2008-11-21 | 2012-04-19 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | β作用薬吸入用のエアロゾル製剤 |
| WO2014056840A1 (en) | 2012-10-09 | 2014-04-17 | Boehringer Ingelheim International Gmbh | Beta-2-adrenoceptor agonist for the treatment of cough |
| EP3551187B1 (en) | 2016-12-12 | 2021-02-17 | Boehringer Ingelheim International GmbH | Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3134590A1 (de) * | 1981-09-01 | 1983-03-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue benzo-heterocyclen |
| US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| JPH0637388B2 (ja) * | 1986-02-17 | 1994-05-18 | 千寿製薬株式会社 | 水性液剤 |
| GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| DE102004019539A1 (de) * | 2004-04-22 | 2005-11-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| ATE539754T1 (de) * | 2004-04-22 | 2012-01-15 | Boehringer Ingelheim Int | Arzneinmittelkombinationen enthaltend benzoxazine zur behandlung von atemwegserkrankungen |
| DE102004024451A1 (de) * | 2004-05-14 | 2005-12-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten |
| DE102004024454A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
-
2004
- 2004-05-14 DE DE102004024452A patent/DE102004024452A1/de not_active Withdrawn
-
2005
- 2005-05-10 EA EA200602017A patent/EA012583B1/ru not_active IP Right Cessation
- 2005-05-10 WO PCT/EP2005/005028 patent/WO2005110421A2/de active Application Filing
- 2005-05-10 HU HUE05747843A patent/HUE027780T2/en unknown
- 2005-05-10 EP EP05747843.0A patent/EP1809293B1/de active Active
- 2005-05-10 BR BRPI0511135A patent/BRPI0511135B8/pt active IP Right Grant
- 2005-05-10 UA UAA200612949A patent/UA87312C2/ru unknown
- 2005-05-10 CA CA2564379A patent/CA2564379C/en active Active
- 2005-05-10 SG SG200902777-2A patent/SG152265A1/en unknown
- 2005-05-10 DK DK05747843.0T patent/DK1809293T3/en active
- 2005-05-10 AU AU2005244414A patent/AU2005244414B2/en active Active
- 2005-05-10 JP JP2007512068A patent/JP4620730B2/ja active Active
- 2005-05-10 CN CNA2005800154865A patent/CN101056640A/zh active Pending
- 2005-05-10 MX MXPA06013216A patent/MXPA06013216A/es active IP Right Grant
- 2005-05-10 ES ES05747843.0T patent/ES2575925T3/es active Active
- 2005-05-10 PL PL05747843.0T patent/PL1809293T3/pl unknown
- 2005-05-10 KR KR1020067026225A patent/KR101288791B1/ko active IP Right Grant
- 2005-05-11 UY UY28891A patent/UY28891A1/es not_active Application Discontinuation
- 2005-05-12 MY MYPI20052158A patent/MY148403A/en unknown
- 2005-05-12 PE PE2005000529A patent/PE20060311A1/es not_active Application Discontinuation
- 2005-05-13 AR ARP050101959A patent/AR049096A1/es unknown
- 2005-05-13 TW TW094115491A patent/TWI356703B/zh not_active IP Right Cessation
-
2006
- 2006-09-06 ZA ZA200607462A patent/ZA200607462B/en unknown
- 2006-11-02 NO NO20065030A patent/NO20065030L/no not_active Application Discontinuation
- 2006-11-13 EC EC2006007004A patent/ECSP067004A/es unknown
- 2006-11-13 IL IL179218A patent/IL179218A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR058082A1 (es) | Formulacion en aerosol para la inhalacion de beta- agonistas | |
| AR049096A1 (es) | Formulacion en aerosol sin gas propelente para la inhalacion de beta-agonistas | |
| AR062424A1 (es) | Formulacion en aerosol para la inhalacion de beta - agonistas | |
| CO6170341A2 (es) | Formulacion de aerosol que contiene derivados de benzoxazin-3onas | |
| NO20061833L (no) | Aerosolformulgering for inhalering, inneholdende anticholinergt middel | |
| DE602006021539D1 (en) | Morpholine als 5ht2c-agonisten | |
| AR041969A1 (es) | Medicamento para el tratamiento de la enfermedad pulmonar obstructiva cronica | |
| RU2006144123A (ru) | Новые энантиомерночистые в-агонисты, способ их получения и их применение в качестве лекарственных средств | |
| RU2006144069A (ru) | Режим приема контрацептива с антагонистом рецептора прогестерона и набор для приема | |
| JP2008503489A (ja) | Ｂｃｌタンパク質と結合パートナーとの相互作用を阻害する化合物および方法 | |
| AR049650A1 (es) | Derivados 5-aril-1h-pirrol[2,3-b]piridin-3-carboxamida o acido 5-aril-1h-pirrol[2,3-b]piridin-3-carboxilico | |
| TW200616636A (en) | Novel compounds | |
| TW200630364A (en) | 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| NZ590987A (en) | Quinuclidine carbonate derivatives and medicinal composition thereof | |
| AR039404A1 (es) | Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion | |
| AR047466A1 (es) | Compuestos derivados de 3h - imidazo[4,5 - b]piridina con actividad inhibidora de quinasa, composiciones farmacéuticas que los contienen como principio activo y su uso en la fabricacion de un medicamento para el tratatmiento de neoplasmas susceptibles. | |
| MX2009010165A (es) | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. | |
| AR039935A1 (es) | Formulacion farmaceutica de liberacion inmediata | |
| AR062477A1 (es) | Formulacion aerosol para la inhalacion de beta - agonistas | |
| AR072802A1 (es) | Derivados piperidinicos de esteres de acido bifenil-2-il-carbamico, antagonistas de receptores muscarinicos m3, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de trastornos digestivos,respiratorios y/o urinarios. | |
| AR059126A1 (es) | Uso de sales de tiotropio en el tratamiento del asma persistente moderada | |
| AR062476A1 (es) | Beta - agonistas enentiomericamente puros, procedimientos para su preparacion y su uso como medicamentos | |
| AR055597A1 (es) | Uso de sales de tiotripio en el tratamiento del asma persistente severa | |
| AR059836A1 (es) | Beta-agonistas enantiomericamente puros, y su uso como medicamentos | |
| AR038764A1 (es) | Formulacion de una solucion de inhalacion con una sal de tiotropio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |